vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Liquidia Corp (LQDA). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $92.0M, roughly 1.0× Liquidia Corp). Liquidia Corp runs the higher net margin — 15.8% vs -98.1%, a 113.9% gap on every dollar of revenue. On growth, Liquidia Corp posted the faster year-over-year revenue change (3054.6% vs 218.6%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Liquidia Corp is a late-stage biopharmaceutical firm focused on developing and commercializing innovative inhaled therapies for respiratory and rare diseases. It uses its proprietary PRINT particle engineering tech to create optimized drug products, with core markets in North America covering pulmonary arterial hypertension and asthma indications.

HIVE vs LQDA — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.0× larger
HIVE
$93.1M
$92.0M
LQDA
Growing faster (revenue YoY)
LQDA
LQDA
+2836.1% gap
LQDA
3054.6%
218.6%
HIVE
Higher net margin
LQDA
LQDA
113.9% more per $
LQDA
15.8%
-98.1%
HIVE

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
LQDA
LQDA
Revenue
$93.1M
$92.0M
Net Profit
$-91.3M
$14.6M
Gross Margin
-27.1%
Operating Margin
21.5%
Net Margin
-98.1%
15.8%
Revenue YoY
218.6%
3054.6%
Net Profit YoY
-234.0%
137.9%
EPS (diluted)
$-0.38
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
LQDA
LQDA
Q4 25
$93.1M
$92.0M
Q3 25
$87.3M
$54.3M
Q2 25
$45.6M
Q4 24
$29.2M
Q3 24
$22.6M
Q2 24
$32.2M
Q4 23
$22.8M
Net Profit
HIVE
HIVE
LQDA
LQDA
Q4 25
$-91.3M
$14.6M
Q3 25
$-15.8M
$-3.5M
Q2 25
$35.0M
Q4 24
$68.2M
Q3 24
$80.0K
Q2 24
$-18.3M
Q4 23
$-24.5M
Gross Margin
HIVE
HIVE
LQDA
LQDA
Q4 25
-27.1%
Q3 25
4.7%
Q2 25
-13.6%
Q4 24
-43.7%
Q3 24
-66.1%
Q2 24
-7.4%
Q4 23
-52.3%
Operating Margin
HIVE
HIVE
LQDA
LQDA
Q4 25
21.5%
Q3 25
3.3%
Q2 25
Q4 24
Q3 24
Q2 24
Q4 23
Net Margin
HIVE
HIVE
LQDA
LQDA
Q4 25
-98.1%
15.8%
Q3 25
-18.1%
-6.5%
Q2 25
76.8%
Q4 24
233.2%
Q3 24
0.4%
Q2 24
-56.7%
Q4 23
-107.8%
EPS (diluted)
HIVE
HIVE
LQDA
LQDA
Q4 25
$-0.38
$0.18
Q3 25
$-0.07
$-0.04
Q2 25
$0.18
Q4 24
$0.52
Q3 24
$0.00
Q2 24
$-0.17
Q4 23
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
LQDA
LQDA
Cash + ST InvestmentsLiquidity on hand
$190.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$44.7M
Total Assets
$624.0M
$327.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
LQDA
LQDA
Q4 25
$190.7M
Q3 25
$157.5M
Q2 25
Q4 24
$40.5M
Q3 24
$31.7M
Q2 24
Q4 23
$4.5M
Stockholders' Equity
HIVE
HIVE
LQDA
LQDA
Q4 25
$559.3M
$44.7M
Q3 25
$624.6M
$22.1M
Q2 25
$560.5M
Q4 24
$430.9M
Q3 24
$275.5M
Q2 24
$268.6M
Q4 23
$122.9M
Total Assets
HIVE
HIVE
LQDA
LQDA
Q4 25
$624.0M
$327.9M
Q3 25
$693.0M
$276.0M
Q2 25
$628.7M
Q4 24
$478.6M
Q3 24
$334.7M
Q2 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
LQDA
LQDA
Operating Cash FlowLast quarter
$46.0M
$44.2M
Free Cash FlowOCF − Capex
$42.2M
FCF MarginFCF / Revenue
45.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
3.04×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
LQDA
LQDA
Q4 25
$46.0M
$44.2M
Q3 25
$-10.6M
$-9.8M
Q2 25
$10.2M
Q4 24
$-28.5M
Q3 24
$-2.2M
Q2 24
$-4.4M
Q4 23
Free Cash Flow
HIVE
HIVE
LQDA
LQDA
Q4 25
$42.2M
Q3 25
$-10.7M
Q2 25
Q4 24
$-55.5M
Q3 24
$-34.7M
Q2 24
Q4 23
FCF Margin
HIVE
HIVE
LQDA
LQDA
Q4 25
45.9%
Q3 25
-19.7%
Q2 25
Q4 24
-189.9%
Q3 24
-153.4%
Q2 24
Q4 23
Capex Intensity
HIVE
HIVE
LQDA
LQDA
Q4 25
2.2%
Q3 25
1.7%
Q2 25
Q4 24
92.5%
Q3 24
143.9%
Q2 24
Q4 23
Cash Conversion
HIVE
HIVE
LQDA
LQDA
Q4 25
3.04×
Q3 25
Q2 25
0.29×
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons